Sovereign Pharma Profile
Key Indicators
- Authorised Capital ₹ 98.00 Cr
as on 17-01-2025
- Paid Up Capital ₹ 24.00 Cr
as on 17-01-2025
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.85 Cr
as on 17-01-2025
- Satisfied Charges ₹ 4.22 Cr
as on 17-01-2025
- Revenue 15.71%
(FY 2024)
- Profit 163.45%
(FY 2024)
- Ebitda 46.60%
(FY 2024)
- Net Worth 70.81%
(FY 2024)
- Total Assets 56.72%
(FY 2024)
About Sovereign Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 98.00 Cr and a paid-up capital of Rs 24.00 Cr.
The company currently has active open charges totaling ₹15.85 Cr. The company has closed loans amounting to ₹4.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sovereign Pharma Private Limited India is Shobhit Jain as COMPANY SECRETARY. Shapoorji Mistry, Cyrus Poonawalla, Adar Poonawalla, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24232MH2003PTC427275
- Company No.
017981
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sovereign Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kairus Dadachanji  | Managing Director | 28-May-2003 | Current |
| Shobhit Jain | Company Secretary | 04-Dec-2023 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rishad Dadachanji | Director | 01-Oct-2021 | Current |
| Piyush Desai | Whole-Time Director | 01-Dec-2021 | Current |
| Makarand Karkare | Director | 01-Dec-2021 | Current |
| Cyrus Poonawalla | Director | 28-May-2003 | Current |
| Adar Poonawalla | Director | 28-May-2003 | Current |
Shapoorji Mistry  | Director | 28-May-2003 | Current |
Financial Performance of Sovereign Pharma.
Sovereign Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 15.71% increase. The company also saw a substantial improvement in profitability, with a 163.45% increase in profit. The company's net worth Soared by an impressive increase of 70.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sovereign Pharma?
In 2024, Sovereign Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shapoorji Pallonji Energy Private LimitedActive 12 years 5 monthsShapoorji Mistry is a mutual person
Kaisha Packaging Private LimitedActive 17 years 4 monthsKairus Dadachanji and Rishad Dadachanji are mutual person
Kairish Innotech Private LimitedActive 4 years 6 monthsKairus Dadachanji and Rishad Dadachanji are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Feb 2023 | ₹1.79 M | Open |
Axis Bank Limited Creation Date: 02 Nov 2022 | ₹3.67 Cr | Open |
Axis Bank Limited Creation Date: 08 Mar 2004 | ₹12.00 Cr | Open |
How Many Employees Work at Sovereign Pharma?
Sovereign Pharma has a workforce of 634 employees as of Jan 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sovereign Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sovereign Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
